Harnessing engineered extracellular vesicles for enhanced therapeutic efficacy: advancements in cancer immunotherapy
Crossref DOI link: https://doi.org/10.1186/s13046-025-03403-w
Published Online: 2025-05-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gong, Zheng
Cheng, Cheng
Sun, Chaonan
Cheng, Xiaoli
Text and Data Mining valid from 2025-05-02
Version of Record valid from 2025-05-02
Article History
Received: 13 February 2025
Accepted: 24 April 2025
First Online: 2 May 2025
Declarations
:
: None.
: The authors declare no competing interests.